Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulimorelin for Recovery of GI Motility After Bowel Resection
NCT01296620Phase 3Completed
- Sponsor
- Tranzyme Pharma
- Start
- Feb 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 6
01
Overview
A Phase 3 trial of ulimorelin in postoperative ileus (POI), sponsored by Tranzyme Pharma. Started Feb 2011; status: completed.
02
Drugs
ulimorelin
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT01296620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01296620.